Who we are
Meet Our Founder & President, Dr. Stephane de Buren
Dr. Stéphane de Buren, Founder and President of DeBuren Group, is a distinguished medical expert with over 33 years of experience across three continents.
He began his medical studies in Switzerland and France, graduating from Geneva University in 1998. Dr. de Buren’s career spans internal medicine, geriatrics, pediatrics, and senior management roles in pharmaceutical marketing with companies like Sanofi and Unilabs.
In 2007, he founded Novacorpus International Healthcare, a leading company in health tourism. Dr. de Buren has appeared in more than 100 articles, radio and television programs. He is a regular speaker at major events.
in 2016, Dr. de Buren also launched a second company, DeBuren Group in Miami, FL, and obtained full Board Certification in Patient Advocacy (PACB) in the US. Today, DeBuren Group is headquartered in Geneva, Switzerland, and specialises exclusively in advising hospitals, physicians, and dentists on attracting and serving patients from Western Europe.
DeBuren Group provides specialised consultancy to help healthcare providers effectively meet the unique needs of Western European patients. We offer expert advice to clinics on how to more easily satisfy these patients, ensuring enhanced patient satisfaction and exceptional care tailored to Western European preferences.
What Our Customers Are Saying
“We’ve been working with Dr. de Buren since 2012, and we couldn’t have achieved this success without his advice.
We appreciate his professionalism on a daily basis and his constant commitment to our business.”
Dr. Cem Zeybek, cosmetic surgeon, Istanbul, Turkey
With our expertise, you’ll succeed in Western European medical tourism
“Having lived, studied and worked in 6 different countries and after more than 100,000 cases,
I know what you need to succeed with Western European patients”
Dr. Stéphane de Buren, President and Founder DeBuren Group
We excel in training doctors, international patient specialists, and hospital staff to successfully engage with Western European patients.
